Fortress Biotech (FBIO)
NASDAQ:FBIO

Fortress Biotech (FBIO) Financial Statements

1,232 Followers

Fortress Biotech Financial Overview

Fortress Biotech's market cap is currently ―. The company's EPS TTM is $-19.52; its P/E ratio is -0.12; Fortress Biotech is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-1.22. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 13.03M$ 34.75M$ 17.39M$ 12.43M$ 16.40M
Gross Profit$ 6.21M$ 28.32M$ 9.19M$ -6.23M$ -7.28M
EBIT$ -33.82M$ -8.71M$ -41.46M$ -62.76M$ -53.51M
EBITDA$ -31.47M$ -5.95M$ -37.94M$ -59.72M$ -50.37M
Net Income Common Stockholders$ -17.73M$ -7.05M$ -26.78M$ -21.54M$ -26.97M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 83.77M$ 72.31M$ 86.77M$ 152.48M$ 178.27M
Total Assets$ 164.65M$ 150.55M$ 180.45M$ 263.55M$ 294.30M
Total Debt$ 81.64M$ 67.15M$ 67.16M$ 116.54M$ 118.70M
Net Debt$ -2.13M$ -5.16M$ -19.61M$ -35.95M$ -59.57M
Total Liabilities$ 168.58M$ 163.79M$ 196.66M$ 243.75M$ 244.28M
Stockholders Equity$ 23.02M$ 16.67M$ 18.51M$ 37.80M$ 41.72M
Cash Flow-
Free Cash Flow$ -25.39M$ -10.80M$ -38.26M$ -43.26M$ -47.94M
Operating Cash Flow$ -25.39M$ -16.80M$ -33.22M$ -43.26M$ -47.84M
Investing Cash Flow-$ 5.00M$ -2.04M$ -5.00M$ -391.00K
Financing Cash Flow$ 27.86M$ -2.69M$ -30.38M$ 22.19M$ 18.62M
Currency in USD

Fortress Biotech Earnings and Revenue History

Fortress Biotech Debt to Assets

Fortress Biotech Cash Flow

Fortress Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis